Henry Schein, Inc. (NASDAQ:HSIC) – Barrington Research increased their Q3 2017 earnings per share (EPS) estimates for Henry Schein in a research note issued to investors on Tuesday. Barrington Research analyst M. Petusky now expects that the company will earn $0.90 per share for the quarter, up from their prior estimate of $0.90.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same period last year, the firm posted $0.82 EPS. The business’s revenue was up 6.4% compared to the same quarter last year.

WARNING: “Henry Schein, Inc. to Post Q3 2017 Earnings of $0.90 Per Share, Barrington Research Forecasts (HSIC)” was published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/25/henry-schein-inc-to-post-q3-2017-earnings-of-0-90-per-share-barrington-research-forecasts-hsic.html.

Other research analysts also recently issued reports about the company. UBS AG reaffirmed a “buy” rating on shares of Henry Schein in a report on Friday, September 15th. Northcoast Research raised Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price target on the stock in a report on Monday, August 7th. Robert W. Baird set a $95.00 price target on Henry Schein and gave the company a “buy” rating in a report on Thursday, October 19th. Morgan Stanley initiated coverage on Henry Schein in a report on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price target on the stock. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $89.00 price target on shares of Henry Schein in a report on Thursday, October 19th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and six have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $92.89.

Shares of Henry Schein (HSIC) opened at 82.97 on Wednesday. The stock has a market capitalization of $13.12 billion, a price-to-earnings ratio of 24.25 and a beta of 1.08. Henry Schein has a 12 month low of $73.11 and a 12 month high of $93.50. The stock’s 50 day moving average price is $82.37 and its 200 day moving average price is $87.29.

A number of institutional investors and hedge funds have recently modified their holdings of HSIC. YorkBridge Wealth Partners LLC increased its position in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after buying an additional 28 shares in the last quarter. Sun Life Financial INC increased its position in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after buying an additional 573 shares in the last quarter. Trust Co. of Vermont increased its position in Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock worth $140,000 after buying an additional 616 shares in the last quarter. Lee Financial Co purchased a new stake in Henry Schein in the second quarter worth about $161,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in Henry Schein by 281.8% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 2,100 shares of the company’s stock worth $172,000 after buying an additional 1,550 shares in the last quarter. Institutional investors and hedge funds own 45.90% of the company’s stock.

In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.19% of the stock is currently owned by corporate insiders.

Henry Schein announced that its Board of Directors has approved a share repurchase program on Monday, September 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its stock is undervalued.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.